The following abbreviations are used in the indicator titles:
The joint monitoring framework (JMF) is used for reporting on indicators under three monitoring frameworks: the Sustainable Development Goals (SDGs), Health 2020 and the Global Action Plan for the Prevention and Control of Noncommunicable Diseases (NCDs) 2013–2020. The Regional Committee for Europe adopted the JMF in September 2018.
The majority of JMF indicators in the Gateway are linked to existing databases in the Gateway.
Background documents
EUR/RC68/10 Rev.1 Briefing note on the expert group deliberations and recommended common set of indicators for a joint monitoring framework
http://www.euro.who.int/en/about-us/governance/regional-committee-for-europe/past-sessions/68th-session/documentation/working-documents/eurrc6810-
EUR/RC68(1): Joint monitoring framework in the context of the roadmap to implement the 2030 Agenda for Sustainable Development, building on Health 2020, the European policy for health and well-being
http://www.euro.who.int/en/about-us/governance/regional-committee-for-europe/past-sessions/68th-session/documentation/resolutions/eurrc68d1
Developing a common set of indicators for the joint monitoring framework for SDGs, Health 2020 and the Global NCD Action Plan (2017)
http://www.euro.who.int/en/health-topics/health-policy/health-2020-the-european-policy-for-health-and-well-being/publications/2018/developing-a-common-set-of-indicators-for-the-joint-monitoring-framework-for-sdgs,-health-2020-and-the-global-ncd-action-plan-2017
Indicator code: E090202.T
SDR is the age-standardized death rate calculated using the direct method, i.e. represents what the crude rate would have been if the population had the same age distribution as the standard European population. ICD-10 code: I20-I25.
Understanding SDR for Ischaemic Heart Disease Across All Ages, per 100 000
The Standardized Death Rate (SDR) for ischaemic heart disease, calculated per 100,000 individuals, serves as a critical health indicator. This metric helps in understanding the impact of this heart condition within populations, irrespective of age. By standardizing rates, it allows for equitable comparisons across different regions and populations, adjusting for age variations. This data is pivotal for health policy makers and researchers, aiming to gauge the burden of ischaemic heart disease globally and to strategize effective prevention and treatment programs.
Methodology Behind Calculating SDR for Ischaemic Heart Disease
To compute the SDR for ischaemic heart disease, epidemiologists use a specific formula that considers the number of deaths attributed to the disease within a given population and year, standardized against a global standard population. This approach helps to nullify the influence of age distribution differences across populations, providing a clearer picture of disease impact. The formula typically involves dividing the total number of disease-specific deaths by the mid-year population, and then multiplying by 100,000 to achieve the rate per 100,000 individuals. This calculation is crucial for maintaining consistency in health data reporting and comparison.
The Significance of SDR in Ischaemic Heart Disease
SDR for ischaemic heart disease is more than a mere statistic; it is a vital health indicator that influences public health decisions and policies. Understanding these rates helps health authorities to identify risk patterns and allocate resources more effectively. It also aids in monitoring the effectiveness of current heart disease interventions and in planning preventive measures. For researchers, this data is essential in identifying epidemiological trends and in conducting comparative studies across different demographics and time periods.
Strengths and Limitations of Using SDR for Ischaemic Heart Disease
While the SDR for ischaemic heart disease is a valuable tool in public health, it comes with its own set of strengths and limitations.
Strengths
The primary advantage of using SDR is its ability to provide a standardized measure, making it possible to compare ischaemic heart disease rates across different populations and over time. This standardization is crucial for health officials and researchers in assessing disease impact and trends globally. Furthermore, SDR helps in the allocation of healthcare resources, planning of health services, and in the evaluation of health programs and interventions aimed at reducing the burden of ischaemic heart disease.
Limitations
However, there are several limitations to consider. The accuracy of SDR depends heavily on the quality of vital registration systems and the completeness of death records. In regions where data collection is inconsistent or incomplete, SDR might not accurately reflect the true disease burden. Additionally, SDR does not account for the morbidity of the disease, meaning it does not provide information on the quality of life or disability caused by ischaemic heart disease. Lastly, while SDR adjusts for age differences, it does not account for other demographic factors like sex or socioeconomic status, which can also influence disease rates.
Understanding both the strengths and limitations of SDR is essential for its effective use in public health monitoring and planning. By acknowledging these factors, health professionals can better utilize SDR data to improve health outcomes and reduce the impact of ischaemic heart disease globally.